相关实验视频
Updated: Jul 5, 2025

05:19
Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
10.1K
在胃食道逆流性疾病 (GORD) 发病过程中的粘膜神经免疫机制
1Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK.
Journal of gastroenterology
|January 14, 2024
概括
胃食道逆流性疾病 (GORD) 涉及与炎症和神经变化相关的内脏疼痛. 本综述探讨了这些因素是如何引起GORD症状的,并寻求新的治疗途径.
科学领域:
- 胃肠病学 胃肠病学
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 胃食道逆流性疾病 (GORD) 引起内脏疼痛,通常对质子抑制剂 (PPI) 没有反应.
- 防腐剂有潜在的长期不良影响,需要替代治疗策略.
- 神经纤维的改变和食道粘膜细胞的变化与GORD病理生理学有关.
研究的目的:
- 审查在GORD中连接炎症和感官感知的分子途径.
- 探索与GORD相关的其他胃肠道疾病的机制.
- 为了确定GORD治疗的新研究方向.
主要方法:
- 关于分子路径的文献综述.
- 免疫细胞和神经纤维相互作用的分析.
- 用刺激性肠综合征 (IBS) 和炎症性肠病 (IBD) 机制进行比较研究.
主要成果:
- 在GORD患者的食道粘膜中的炎症有助于宏观和微观炎症.
- 观察到免疫细胞和粘膜神经之间的双向相互作用,类似于IBS和IBD.
- 炎症过程可以驱动神经纤维外生和过敏等感官变化,促进疼痛信号传递.
结论:
- 了解炎症和感觉神经之间的相互作用对于GORD的发病过程至关重要.
- 来自其他胃肠道疾病的机制可能为新的GORD治疗点提供见解.
- 对这些分子通路的进一步研究可能会导致改善GORD管理.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
592
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
319
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
319
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
Gastritis-II: Pathophysiology
330
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
330
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Peptic Ulcer Disease II: Pathophysiology
438
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
438

